The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
FILE PHOTO: A woman holds a small bottle labeled with a"Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
- The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday. It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority on a not-for-profit basis to be used after approval or emergency use authorization by the U.S. Food and Drug Administration .
J&J has already received $1 billion in funding from the U.S. government - BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine. The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the U.S government, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc (
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion
Read more »
A bill would spend $1 billion on diversifying med schools to close the racial health gapA recently introduced bill seeks to help encourage more young doctors of color through a $1B grant to several medical schools.
Read more »
Dr. Dre's Wife is Challenging Prenup in $1 Billion DivorceDr. Dre's wife is not getting divorced without a fight, because she's challenging their prenup and $1 billion is on the line.
Read more »
Rippling, Founded By Fallen Tech CEO Parker Conrad, Passes $1 Billion Valuation With $145 Million FundraiseThe latest tech unicorn: HR software startup Rippling, founded by Parker Conrad, who previously rose and fell with Zenefits. Forbes previously wrote about Conrad's efforts at redemption with Rippling as part of our Next Billion-Dollar Startups list.
Read more »
Novavax's coronavirus vaccine generates promising immune response in early trial, data showsNovavax's potential vaccine to prevent Covid-19 generated a promising immune response in an early-stage clinical trial, the U.S.-based biotech firm announced Tuesday.
Read more »
Want to Keep Safe From COVID-19? Ignore TrumpDespite the horror that COVID-19 has unleashed upon the American people, President Donald Trump gave yet another lie-filled interview about U.S. COVID-19 response on Monday.
Read more »